Microviable Therapeutics to enter into a contractual agreement with BCD Bioscience.

2022-03-29T18:52:27+02:0029 de March de 2022|

Microviable Therapeutics SL (Gijón, Asturias, Spain), announced a contractual agreement with BCD Bioscience Inc. (California, USA) to work on microbial fermentation and novel prebiotics to modulate the human gut microbiome. Microviable expertise on gut microbiome research [...]